News

Patient Engagement Lead to Address iCAN Summit July 12

DURHAM, N.C., July 2, 2018 — Premier Research’s head of patient engagement will talk about the role of natural history studies in clinical research at the International Children’s Advisory Network’s Research & Advocacy Summit on July 12 in Edinburgh, U.K. Juliet Moritz, the CRO’s Executive Director, Program Strategy, Rare Disease and Pediatrics/Patient Engagement, will discussRead more





First Premier Research Podcast Explores Rare Cancer Trials

DURHAM, N.C., JUNE 2, 2018 — Premier Research is sharing the viewpoints and insights of its clinical trial experts through a podcast that launches today. The inaugural edition of the Premier Voices podcast focuses on rare oncology drug development, and its introduction coincides with the American Society of Clinical Oncology’s annual meeting June 1-5 inRead more





Premier Research Receives Magazine’s 2018 CRO Leadership Award

DURHAM, N.C., APRIL 27, 2018 — Premier Research has been named a 2018 CRO Leadership Award winner by Life Science Leader magazine. The publication annually asks pharmaceutical and biopharma companies to rate the capability and performance of contract research organizations. Premier Research was recognized in five of six award categories: Capabilities — the company’s accessRead more





Planning Rare Disease Studies: Our Top Expert to Address WODC

DURHAM, N.C., APRIL 23, 2018 — Premier Research’s top rare disease and pediatrics expert will discuss clinical trial planning at the World Orphan Drug Congress in Oxon Hill, Maryland. Angi Robinson, Executive Director, Strategic Development, Rare Disease & Pediatrics, will present Early Development Planning for Orphan Drugs: Tasks, Timelines, and Takeaways on Thursday, April 26,Read more





Advancing Drug Development: Join Us at Clin Ops in Oncology West

DURHAM, N.C., APRIL 20, 2018 — A Premier Research oncology expert will discuss advances in the development of cancer drugs at Clinical Operations in Oncology Trials West Coast in Burlingame, California. Brian Huber, Executive Director for Oncology Strategic Development, will present Transforming the Oncology Drug Development Process on Tuesday, April 24, at 10 a.m. Mr.Read more





Premier Research Comes on Strong in Clinical Researcher of the Year Competition

DURHAM, N.C., March 30, 2018 — Fourteen Premier Research employees have been named finalists for PharmaTimes magazine’s Clinical Researcher of the Year awards. The finalists are three clinical trial managers, two project managers, and nine members of two project teams. Competition continues through to April 27, when the awards are announced. Finalists in the Clinical TrialRead more





Expert to Discuss Trial Cost Forecasting at Industry Financial Summit

DURHAM, N.C., March 30, 2018 — Predicting the cost of clinical trials is a complex task, and more CROs are providing grant forecasting as a service to produce more accurate projections and give customers greater visibility. A grant forecasting expert from Premier Research will discuss new approaches to predicting trial costs in April at theRead more





Pain Expert to Discuss Osteoarthritis Trials at APS 2018

DURHAM, N.C., MARCH 2, 2018 — You know that well-worn advice about picking investments: that past performance doesn’t guarantee future results. The same can be said of selecting clinical trial sites, as Premier Research’s top analgesia expert will explore at the American Pain Society’s 2018 Scientific Summit on March 6 in Anaheim. Michael Kuss, ViceRead more





February 20 Webinar to Explore Immuno-Gene Research in Blood Cancers

DURHAM, N.C., FEBRUARY 16, 2018 — Biotech innovators exploring new outsourcing models to develop hematological cancer drugs should attend our February 20 webinar. Presented by Luke Gill, Vice President Oncology, Clinical Development Services, and Colin Hayward, Chief Medical Officer, Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Strategy will cover the latest research trends in immuno-oncology and gene therapy andRead more





Are We Trading Speed for Innovation in Approving New Drugs?

DURHAM, N.C., February 16, 2018 — Are expedited approvals of new drugs occurring at the expense of innovation? Nach Davé, Vice President of Global Regulatory Affairs at Premier Research, will explore the subject at Outsourcing in Clinical Trials West Coast 2018, February 21 in Burlingame, California. In his presentation, Faster Approvals but Less Innovation: TrendRead more





Experts to Discuss EU Regulations at OCT Medical Devices Europe

DURHAM, N.C., February 6, 2018 — Two Premier Research medical device experts will examine the impact of upcoming changes to European medical device regulations at Outsourcing in Clinical Trials Medical Devices Europe 2018. Joanne Emmett, Vice President for Medical Device and Diagnostics, and Janet Kube, Director, Project Management, will discuss the new EU Medical DeviceRead more





December 12 Webinar Examines Heart Valve Devices

DURHAM, N.C., DECEMBER 12, 2017 — When conducting clinical research on heart valve replacement and repair devices, fully engaging the entire trial team is vital to achieving effective operational oversight. Premier Research will examine why — and offer practical advice to medical device makers — at a live webinar on Tuesday, December 12 (11 a.m.Read more





Phone Us Now
Email Us Now